Biblio

Author Title [ Type(Desc)] Year
Filters: Author is Chen, Dong  [Clear All Filters]
Journal Article
Zhou Y-W, Ren Y, Lu M-M, Xu L-L, Cheng W-X, Zhang M-M, Ding L-P, Chen D, Gao J-G, Du J, et al. Crohn's disease as the intestinal manifestation of pan-lymphatic dysfunction: An exploratory proposal based on basic and clinical data. World J Gastroenterol. 2024;30(1):34-49.
Gassenmaier M, Chen D, Buchner A, Henkel L, Schiemann M, Mack B, Schendel DJ, Zimmermann W, Pohla H. CXC chemokine receptor 4 is essential for maintenance of renal cell carcinoma-initiating cells and predicts metastasis. Stem Cells. 2013.
Cao J, Li A, Pei R, Lu Y, Chen D, Du X, Liu X, Li S, Ye P. Effectiveness of single-dose 6 mg pegfilgrastim in mobilizing peripheral blood stem cells in allogeneic hematopoietic cell transplantation donors. Ann Hematol. 2023.
Wang Y, Gao T, Li W, Tai C, Xie Y, Chen D, Liu S, Huang F, Wang W, Chen Y, et al. Engineered clinical-grade mesenchymal stromal cells combating SARS-CoV-2 omicron variants by secreting effective neutralizing antibodies. Cell Biosci. 2023;13(1):160.
Cao J, Pei R, Lu Y, Zheng Z, Yuan Z, Li D, Zhang P, Liu X, Chen D, Du X, et al. Fludarabine and antithymocyte globulin-based conditioning regimen combined with post-transplantation cyclophosphamide for haploidentical allogeneic hematopoietic stem cell transplantation in patients with high-risk acute myeloid leukemia and myelodysplast. Curr Res Transl Med. 2022;71(1):103360.
Sun J, Zhang X, Cong Q, Wang C, Chen D, Wang Y, Wang X, Yi Z, Qin S. Generation of refractory schizophrenia patient-derived induced pluripotent stem cell line UJSi001-A. Stem Cell Res. 2019;38:101460.
Ye P, Pei R, Lian J, Chen D, Li S, Cheng Y, Li F, Yuan J, Chen Y, Lu Y. Higher efficacy of Etoposide + Cytarabine Plus Pegfilgrastim in poorly mobilizing Multiple Myeloma and lymphoma Patients. Cytotherapy. 2023.
Cao J, Xu X, Lu Y, Wang T, Chen D, Li S, Liu X, Ye P, Zheng Z-Z, Pei R. Intensified conditioning regimen with fludarabine combined with post-transplantation cyclophosphamide for haploidentical allogeneic hematopoietic stem cell transplantation in children with high-risk acute leukemia. Hematology. 2023;28(1):2223873.
Tang S, Lu Y, Zhang P, Chen D, Liu X, Du X, Cao J, Ye P, Chen L, Li S, et al. Lenalidomide, bortezomib and dexamethasone followed by tandem- autologous stem cell transplantation is an effective treatment modality for multi-hit multiple myeloma. Leuk Res. 2021;110:106710.
Han S, Xu Y, Chen D, Yang F, Wang M, Zhou Q, Wang G, Li L, Xu C, Wang W, et al. Notch activation defines immune-suppressive subsets of ccRCCs with unfavorable benefits from immunotherapy over VEGFR/mTOR inhibitors. iScience. 2024;27(1):108290.
Cao J, Pei R, Lu Y, Chen D, Du X, Liu X, Li S. The Proportion of Myeloid-derived Suppressor Cells in the Graft as a Potential Predictor of Acute Graft-versus-host Disease in Haploid Allogeneic Hematopoietic Stem Cell Transplantation. J Immunother. 2023.